These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6300455)

  • 41. Characterization of viral RNA in cells transformed by various isolates of Moloney murine sarcoma virus.
    Hamelin R; Devaux J; Honoré N; Auger-Buendia MA; Tavitian A
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2057-62. PubMed ID: 6310043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus.
    Shih TY; Weeks MO; Young HA; Scholnick EM
    Virology; 1979 Jul; 96(1):64-79. PubMed ID: 223311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiserum to murine leukemia virus recognizes novel cell surface molecules associated with growth control and transformation.
    Rieber M; Rieber M; Alonso M
    Int J Cancer; 1979 Apr; 23(4):547-54. PubMed ID: 86526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and partial characterization of a 55,000-dalton protein induced in cells transformed by the ml strain of Moloney murine sarcoma virus.
    Wood TG; Somers K; Arlinghaus RB
    Virology; 1980 Aug; 105(1):148-58. PubMed ID: 6251602
    [No Abstract]   [Full Text] [Related]  

  • 45. Phosphorylation of v-mos Ser 47 by the mitotic form of p34cdc2.
    Bai WL; Singh B; Karshin WL; Shonk RA; Arlinghaus RB
    Oncogene; 1991 Oct; 6(10):1715-23. PubMed ID: 1833715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological and molecular biological characterization of the virus progeny from transformed clones MuSV-124 and MuSV-349: evidence for MuLV-specific nucleotide sequences in the MoMuSV size class of RNA from MoMuSV-124.
    Dekaban GA; Ball JK; Loosmore SM; McCarter JA
    J Gen Virol; 1980 Apr; 47(2):407-22. PubMed ID: 6245178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos.
    Maxwell SA; Arlinghaus RB
    J Virol; 1985 Sep; 55(3):874-6. PubMed ID: 2991608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of transforming gene products from Moloney murine sarcoma virus.
    Papkoff J; Lai MH; Hunter T; Verma IM
    Cell; 1981 Nov; 27(1 Pt 2):109-19. PubMed ID: 6276018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro cleavage of Pr65gag by the Moloney murine leukaemia virus proteolytic activity yields p30 whose NH2-terminal sequence is identical to virion p30.
    Yoshinaka Y; Shames RB; Luftig RB; Smythers GW; Oroszlan S
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():379-83. PubMed ID: 2578553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus.
    Barbacid M; Beemon K; Devare SG
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5158-62. PubMed ID: 6254060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moloney murine sarcoma virus MuSVts110 DNA: cloning, nucleotide sequence, and gene expression.
    Huai L; Chiocca SM; Gilbreth MA; Ainsworth JR; Bishop LA; Murphy EC
    J Virol; 1992 Sep; 66(9):5329-37. PubMed ID: 1501276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of retrovirus-associated protein kinase and proteins to Staphylococcus aureus.
    Kloetzer WS; Arlinghaus RB
    J Gen Virol; 1982 Jun; 60(Pt 2):365-70. PubMed ID: 6955449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell cycle-mediated structural and functional alteration of P85gag-mos protein kinase activity.
    Liu JX; Singh B; Wlodek D; Arlinghaus RB
    Oncogene; 1990 Feb; 5(2):171-8. PubMed ID: 2138725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Further characterization of the in vitro products generated by proteolytic cleavage of Gazdar murine sarcoma virus p65gag.
    Maxwell SA; Arlinghaus RB
    J Gen Virol; 1985 Jan; 66 ( Pt 1)():97-107. PubMed ID: 2981963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization.
    Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.
    Stocking C; Kollek R; Bergholz U; Ostertag W
    Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity.
    Yoshinaka Y; Luftig RB
    Virology; 1982 Apr; 118(2):380-8. PubMed ID: 6178211
    [No Abstract]   [Full Text] [Related]  

  • 58. Partial characterization of a moloney murine sarcoma virus 85,000-dalton polypeptide whose expression correlates with the transformed phenotype in cells infected with a temperature-sensitive mutant virus.
    Horn JP; Wood TG; Blair DG; Arlinghaus RB
    Virology; 1980 Sep; 105(2):516-25. PubMed ID: 7423857
    [No Abstract]   [Full Text] [Related]  

  • 59. The P55 protein affected by v-mos expression is vimentin.
    Singh B; Goldman R; Hutton L; Herzog NK; Arlinghaus RB
    J Virol; 1987 Nov; 61(11):3625-9. PubMed ID: 2822968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.
    Schultz AM; Copeland TD; Mark GE; Rapp UR; Oroszlan S
    Virology; 1985 Oct; 146(1):78-89. PubMed ID: 2994296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.